Self-Administered Parenteral Market Expansion Outlook: $30.83 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Self-Administered Parenteral Market From 2025 To 2034?

The self-administered parenteral market has experienced significant growth in recent years. It is forecast to expand from $24.57 billion in 2024 to $25.84 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.2%. Historically, this growth has been propelled by an escalation in chronic diseases, an aging population, government initiatives, patient education and support programs, and the increasing occurrences of bone disorders.

The self-administered parenteral market is anticipated to experience consistent expansion over the upcoming years. Projections indicate it will reach $30.83 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.5%. This projected growth is driven by factors such as a rising patient inclination for home healthcare, the adoption of telemedicine and remote patient monitoring, patient education and support programs, and the expansion of personalized medicine. Key trends expected during this period encompass the incorporation of digital health solutions, development of customized drug delivery systems, the rise of targeted therapies, and progress in biologics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

What Are The Main Drivers Boosting The Self-Administered Parenteral Industry’s Expansion?

The increasing occurrence of chronic diseases is anticipated to boost the expansion of the self-administered parenteral market in the future. These are persistent health issues that typically evolve gradually and frequently necessitate continuous care and therapy. Self-administered parenteral products play a role in handling chronic conditions by enabling patients to administer their own treatment, leading to considerably better compliance than oral alternatives. For instance, data from a US-based government agency, the National Institutes of Health, indicated in January 2023, that the population aged 50 or above with at least one chronic disease is projected to rise by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Consequently, the increasing prevalence of chronic diseases is propelling the expansion of the self-administered parenteral market.

What Are The Major Segments Identified In The Self-Administered Parenteral Market?

The self-administered parenteralmarket covered in this report is segmented –

1) By Product: Pre-Filled Syringes; Autoinjectors; Pen Injectors; Other Products

2) By Usage: Disposable; Reusable

3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Home Healthcare Providers; Specialty Clinics; Other Distribution Channels

4) By Application: Cardiovascular Diseases; Diabetes; Osteoporosis; Pain Management; Hormone Replacement; Other Applications

Subsegments:

1) By Pre-Filled Syringes: Glass Pre-Filled Syringes; Plastic Pre-Filled Syringes

2) By Autoinjectors: Disposable Autoinjectors; Reusable Autoinjectors

3) By Pen Injectors: Insulin Pen Injectors; Growth Hormone Pen Injectors; Other Pen Injectors

4) By Other Products: Infusion Pumps; Needle-Free Injectors; Combination Devices

What Key Innovation Trends Are Fueling Advancements In The Self-Administered Parenteral Market?

Companies operating within the self-administered parenteral market are concentrating on developing innovative products, such as the UDENYCA autoinjector, aiming to offer expanded choice and improved control, thereby enhancing patient access to treatment. An autoinjector is a medical instrument designed to administer a single dose of a specific drug, featuring an intuitive design where administration is triggered instantly and dependably via push-on-skin activation. For instance, in May 2023, Coherus BioSciences Inc., a US-based biotech firm, introduced the UDENYCA autoinjector, a self-administered parenteral medication, in the US. The UDENYCA Autoinjector is a prefilled, single-dose autoinjector that provides patients with an additional administration method for pegfilgrastim. Its intuitive design, activated by push-on-skin, ensures reliable and immediate delivery of a full pegfilgrastim dose. Additionally, it incorporates several user-centric features to facilitate successful delivery, including rapid dosing, intuitive design, dual coverage, suitability for at-home and in-office use, and a reduced risk of febrile neutropenia.

Which Major Industry Participants Are Leading The Self-Administered Parenteral Market Growth?

Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

Which Region Is Projected To Lead The Self-Administered Parenteral Market During The Forecast Period?

North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Self-Administered Parenteral Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13927&type=smp

Browse Through More Reports Similar to the Global Self-Administered Parenteral Market 2025, By The Business Research Company

Payer Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/payer-services-global-market-report

Personal Computers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-computers-global-market-report

Physician And Other Health Practitioner Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/physician-and-other-health-practitioner-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795